Skip to main content
Advertisement

Meningitis Vaccine Eligibility Expanded as Kent Outbreak Reaches 27 Cases

Kent's meningitis outbreak rises to 27 cases, prompting expanded vaccine eligibility and antibiotic distribution at universities. UKHSA stresses vaccine limits and urges awareness of symptoms.

·4 min read
Students wearing face masks queue up to get vaccinated at the University of Kent in Canterbury,

Meningitis Cases Rise in Kent

Seven new cases of meningitis have been confirmed in Kent, bringing the total number of cases to 27, according to the UK Health Security Agency (UKHSA).

Officials believe that the current approach, which includes preventive antibiotics and targeted vaccination, is effective. The outbreak is caused by a known strain of meningitis B bacteria, has reported.

Unusual Scale of Outbreak

The reason behind the unusually large outbreak remains unclear. Speaking on BBC Breakfast on Thursday, Professor Robin May, Chief Scientific Officer at UKHSA, stated:

“What is particularly remarkable about this case, and unexpected about this case, is the large number of cases all originating from what seems to be a single event.
“There are two possible reasons for that. One is that there might be something about the kind of behaviours that individual people are doing. The other possibility is the bacteria itself may have evolved to be better at transmitting.”

UKHSA reported on Thursday that 15 cases had been confirmed through laboratory testing, while 12 notifications remained under investigation.

Vaccination and Antibiotic Measures at Universities

At the University of Kent’s Canterbury campus, 600 meningitis B vaccines have been administered. Additionally, more than 6,500 precautionary doses of antibiotics have been distributed to students. Tragically, one school pupil and one university student have died, with officials describing the situation on Wednesday as the most significant outbreak in the UK in recent years.

Canterbury Christ Church University, also located in Kent, confirmed on Wednesday that one of its students had contracted meningitis. This means that confirmed or suspected cases have now been reported at two universities and four schools in the region.

Advertisement

UKHSA also noted that one student at a higher education institution in London has meningitis linked directly to the Kent outbreak.

Understanding Meningitis B

Meningitis is an infection affecting the protective lining of the brain and spinal cord. It can be caused by various bacteria and viruses. Meningitis B is caused by the Neisseria meningitidis bacteria, also known as meningococcus. This bacterium typically resides harmlessly in the throats of many people but can cause severe, life-threatening disease if it enters the bloodstream or spinal fluid. Prompt antibiotic treatment is critical.

Public Health Guidance and Response

General practitioners (GPs) across England were instructed on Wednesday to prescribe antibiotics to anyone who attended Club Chemistry, a nightclub in Canterbury, between 5 and 7 March, as well as to students who had left the University of Kent campus.

The UKHSA has issued an alert to the wider NHS in England regarding the signs and symptoms of meningitis. However, the agency emphasized that this alert does not indicate that the outbreak is expected to spread nationwide.

Vaccination and Awareness

Trish Mannes, UKHSA’s Regional Deputy Director for South-East England, highlighted the importance of vaccination and awareness:

“Two doses of the MenB vaccine helps protect individuals against meningococcal B disease. It is important to know that the MenB vaccine does not protect against all strains of meningococcal disease, nor against all infections that can cause meningitis. It also does not prevent the bacteria from being carried and spread in the community.
“It is therefore still hugely important that people are aware of the signs and symptoms of invasive meningococcal disease, and that they seek immediate medical attention if they or anyone they know develops these signs and symptoms.”
“If you have been offered preventative antibiotics, it is strongly recommended that you take them promptly. If you are a student at the University of Kent who is eligible but has since returned home, contact your local GP, who will be able to provide advice and prescribe the appropriate treatment.”

The UKHSA also reassured the public that the NHS has an adequate supply of MenB vaccines, following reports from pharmacies of difficulties obtaining the vaccine for private purchase.

All reported cases so far have a confirmed link to Kent, according to the UKHSA.

This article was sourced from theguardian

Advertisement

Related News